Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
NGENNervgen Pharma	$154.97m	n/a	n/a
CNTNCanton Strategic Holdings	$153.79m	n/a	n/a
MGNXMacroGenics	$151.61m	n/a	n/a
STROSutro Biopharma	$151.55m	n/a	n/a
ANTXAN2 Therapeutics	$149.25m	n/a	n/a
TARAProtara Therapeutics	$148.92m	n/a	n/a
MSCLSatellos Bioscience	CA$203.68m	n/a	n/a
MRSNMersana Therapeutics	$145.16m	n/a	n/a
ALXOALX Oncology Holdings	$143.66m	n/a	n/a
NBPNovaBridge Biosciences	$140.36m	n/a	n/a
MENSJyong Biotech	$139.56m	n/a	n/a
ADAGAdagene	$135.63m	n/a	n/a
SPRBSpruce Biosciences	$134.56m	n/a	n/a
PRDSPardes Biosciences	$133.95m	n/a	n/a
CATXPerspective Therapeutics	$133.56m	n/a	n/a
HURATuHURA Biosciences	$131.28m	n/a	n/a
CUECue Biopharma	$130.83m	n/a	n/a
HUMAHumacyte	$130.51m	n/a	n/a
NGMNGM Biopharmaceuticals	$128.53m	n/a	n/a
KNTEKinnate Biopharma	$125.62m	n/a	n/a